Woodline Partners’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.15M | Sell |
|
|||||
|
2025
Q2 | $22.1M | Buy |
|
|||||
|
2025
Q1 | $15.8M | Sell |
|
|||||
|
2024
Q4 | $18.1M | Sell |
|
|||||
|
2024
Q3 | $20.6M | Buy |
|
|||||
|
2024
Q2 | $16.9M | Buy |
|
|||||
|
2024
Q1 | $6.96M | Hold |
|
|||||
|
2023
Q4 | $5.48M | Hold |
|
|||||
|
2023
Q3 | $5.41M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $3.54M | Hold |
|
|||||
|
2022
Q3 | $1.98M | Sell |
|
|||||
|
2022
Q2 | $1.16M | Sell |
|
|||||
|
2022
Q1 | $1.93M | Buy |
|
|||||
|
2021
Q4 | $653K | Buy |
|
|||||
|
2021
Q3 | $547K | Buy |
|